Autonomic Nervous System Drugs Practice Questions

Q: Which of the following drugs used in Benign Prostatic Hyperplasia (BHP) has a negligible risk of causing postural hypotension?

Silodosin. ### Explanation The correct answer is **Silodosin**. **1. Why Silodosin is correct:** The primary goal in treating Benign Prostatic Hyperplasia (BPH) is to relax the smooth muscles of the prostate and bladder neck. This is mediated by **$\alpha_{1A}$-adrenergic receptors**. However, blood pressure regulation is primarily mediated by **$\alpha_{1B}$-adrenergic receptors** located in the vascular smooth muscle. Silodosin (along with Tamsulosin) is a **highly selective $\alpha_{1A}$ blocker** [2]. Because it has minimal affinity for $\alpha_{1B}$ receptors, it does not cause significant peripheral vasodilation [1]. Consequently, it effectively relieves urinary symptoms with a **negligible risk of postural (orthostatic) hypotension**, making it safer for elderly patients or those already on antihypertensives [1], [2]. **2. Why the other options are incorrect:** * **Prazosin, Terazosin, and Doxazosin:** These are **non-selective $\alpha_1$ blockers**. They block both $\alpha_{1A}$ (prostate) and $\alpha_{1B}$ (blood vessels) receptors. While effective for BPH, their potent vasodilatory effect frequently leads to "first-dose phenomenon," syncope, and significant postural hypotension [1]. **3. Clinical Pearls for NEET-PG:** * **Uro-selectivity:** Silodosin > Tamsulosin > Alfuzosin. * **Side Effect Profile:** While Silodosin has the least cardiovascular risk, it has the highest incidence of **retrograde ejaculation** (due to $\alpha_{1A}$ blockade in the vas deferens) [1]. * **IFIS:** All $\alpha_1$ blockers are associated with **Intraoperative Floppy Iris Syndrome (IFIS)** during cataract surgery; the drug should be stopped prior to the procedure. * **Long-acting agents:** Doxazosin and Terazosin have longer half-lives compared to Prazosin and are also used in the management of hypertension.

Q: Which of the following is the mechanism of action of the new drug Rhopressa for glaucoma treatment?

Increased trabecular meshwork outflow. **Explanation:** **Rhopressa (Netarsudil)** is a first-in-class **Rho-kinase (ROCK) inhibitor** recently approved for the treatment of open-angle glaucoma and ocular hypertension. **1. Why Option B is Correct:** The primary mechanism of Netarsudil is the **increase of aqueous outflow through the trabecular meshwork (TM)**, which is the "conventional" outflow pathway. It works by inhibiting the Rho-kinase enzyme, leading to the relaxation of the actin-myosin cytoskeleton within the trabecular meshwork cells and the contraction of the inner wall of Schlemm’s canal. This reduces resistance and increases the ease with which fluid leaves the eye. Additionally, it lowers episcleral venous pressure. **2. Why the Other Options are Incorrect:** * **Option A:** Increased uveoscleral (unconventional) outflow is the primary mechanism of **Prostaglandin Analogues** (e.g., Latanoprost). * **Option C:** Increasing aqueous production would raise intraocular pressure (IOP) and is contraindicated in glaucoma management. * **Option D:** Decreased aqueous production is the mechanism of **Beta-blockers** (e.g., Timolol), **Alpha-2 agonists** (e.g., Brimonidine), and **Carbonic Anhydrase Inhibitors** (e.g., Dorzolamide). **Clinical Pearls for NEET-PG:** * **Triple Action:** Netarsudil is unique because it (1) increases TM outflow, (2) decreases episcleral venous pressure, and (3) slightly reduces aqueous production (minor effect). * **Side Effects:** The most common side effect is **conjunctival hyperemia** (redness) and **conjunctival hemorrhages** (petechiae). It can also cause **cornea verticillata** (vortex keratopathy). * **Dosing:** It is typically administered as a once-daily drop in the evening.

Q: Which of the following drugs is contraindicated in glaucoma?

Atropine. **Explanation:** The correct answer is **Atropine**. **Why Atropine is Contraindicated:** Atropine is a potent **parasympatholytic (anticholinergic)** drug. It causes **mydriasis** (dilation of the pupil) and **cycloplegia** (paralysis of the ciliary muscle). In individuals with narrow anterior chamber angles, mydriasis causes the peripheral iris to bunch up and block the trabecular meshwork. This obstructs the outflow of aqueous humor, leading to a rapid rise in intraocular pressure (IOP), which can precipitate an attack of **Acute Angle-Closure Glaucoma**. Additionally, by relaxing the ciliary muscle, it decreases the tension on the scleral spur, further reducing trabecular outflow. **Analysis of Incorrect Options:** * **Adrenaline:** Though rarely used now due to side effects, it was historically used in open-angle glaucoma as it increases uveoscleral outflow and decreases aqueous production. It is avoided in narrow-angle glaucoma but is not as strictly contraindicated as Atropine. * **Timolol:** A non-selective **beta-blocker**, it is a first-line treatment for glaucoma. It works by decreasing the production of aqueous humor from the ciliary body. * **Pilocarpine:** A **miotic (parasympathomimetic)** drug. It is used to treat glaucoma because it causes pupillary constriction and contraction of the ciliary muscle, which opens the trabecular meshwork and enhances aqueous drainage. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Acute Angle-Closure Glaucoma:** IV Acetazolamide (to lower IOP) and Pilocarpine (once IOP is <30 mmHg). * **Mydriatic of choice for fundus examination in adults:** Tropicamide (shorter duration of action than Atropine). * **Safe Mydriatic in Glaucoma:** Phenylephrine (an alpha-1 agonist) is preferred because it causes mydriasis without cycloplegia, though it must still be used with caution in narrow angles.

Q: Alpha bungarotoxin acts at which site?

Acetylcholine receptors. **Explanation:** **Alpha-bungarotoxin** is a potent neurotoxin derived from the venom of the many-banded krait (*Bungarus multicinctus*). Its primary mechanism of action is the **irreversible competitive blockade of nicotinic acetylcholine receptors (nAChR)** at the motor endplate of the neuromuscular junction. By binding with high affinity to the alpha subunits of these receptors, it prevents acetylcholine (ACh) from binding, leading to flaccid paralysis and respiratory failure. **Analysis of Options:** * **Option B (Correct):** Alpha-bungarotoxin acts directly on the **postsynaptic receptors**. It is widely used in research to quantify and localize nicotinic receptors due to its nearly irreversible binding. * **Option A (Incorrect):** ACh synthesis is primarily inhibited by drugs like **Hemicholinium** (which blocks choline uptake). * **Option C & D (Incorrect):** Inhibition of ACh release/secretion from the presynaptic terminal is the mechanism of **Botulinum toxin** (which cleaves SNARE proteins) and **Beta-bungarotoxin** (which has phospholipase A2 activity). **High-Yield Clinical Pearls for NEET-PG:** * **Alpha-bungarotoxin:** Postsynaptic blocker (similar to d-tubocurarine but irreversible). * **Beta-bungarotoxin:** Presynaptic blocker (inhibits ACh release). * **Snake Venom Correlation:** The paralysis caused by krait venom is often poorly reversed by neostigmine because alpha-bungarotoxin binds so tightly to the receptor. * **Diagnostic Use:** Radioactive iodine-labeled alpha-bungarotoxin is used in the diagnosis and study of **Myasthenia Gravis** to measure the number of functional nicotinic receptors.

Q: A patient is administered pilocarpine. All of the following can be the features seen in him except?

Cycloplegia. **Explanation:** Pilocarpine is a **direct-acting cholinergic agonist** (parasympathomimetic) that primarily acts on muscarinic receptors ($M_1, M_2, M_3$). To answer this question, one must distinguish between drugs that stimulate the parasympathetic nervous system versus those that block it. **Why Cycloplegia is the Correct Answer:** Cycloplegia refers to the **paralysis of the ciliary muscle**, resulting in the loss of accommodation. This is a characteristic effect of **anticholinergic** drugs (like Atropine) which block $M_3$ receptors. In contrast, Pilocarpine causes **contraction** of the ciliary muscle (spasm of accommodation), which leads to "cyclospasm" and blurring of distant vision, not cycloplegia. **Analysis of Incorrect Options:** * **Sweating (A):** Pilocarpine is a potent diaphoretic. Although sweat glands are part of the sympathetic system anatomically, they are mediated by **cholinergic ($M_3$) receptors**. Thus, pilocarpine significantly increases sweating. * **Salivation (B):** As a parasympathomimetic, pilocarpine stimulates exocrine glands. It is clinically used to treat xerostomia (dry mouth) in Sjogren’s syndrome. * **Miosis (C):** Pilocarpine causes contraction of the **sphincter pupillae** muscle of the iris, leading to pupillary constriction (miosis). This action helps open the trabecular meshwork, making it useful in treating glaucoma. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Pilocarpine is the DOC for **Acute Angle Closure Glaucoma** (to rapidly induce miosis). * **Ciliary Muscle:** Contraction (Pilocarpine) = Accommodation for near vision; Relaxation (Atropine) = Cycloplegia (loss of accommodation). * **Side Effect:** The most common side effect of ophthalmic pilocarpine is brow ache due to ciliary muscle spasm.

Q: What is the primary mechanism of action of brimonidine in glaucoma?

Decreased aqueous humor secretion. **Explanation:** **Brimonidine** is a highly selective **alpha-2 ($\alpha_2$) adrenergic agonist** used in the management of open-angle glaucoma and ocular hypertension. **1. Why Option A is Correct:** The primary mechanism of brimonidine is the **reduction of aqueous humor production**. It acts on $\alpha_2$ receptors located on the ciliary body epithelium. Stimulation of these G-protein coupled receptors leads to a decrease in intracellular cAMP, which in turn inhibits the active secretion of aqueous humor by the ciliary processes. **2. Analysis of Other Options:** * **Option B (Increased trabecular outflow):** This is the primary mechanism of **Miotics** (e.g., Pilocarpine), which contract the ciliary muscle to open the trabecular meshwork. * **Option C (Increased uveoscleral outflow):** While brimonidine has a secondary, delayed effect of increasing uveoscleral outflow (via prostaglandin release), its **primary** and immediate action is the suppression of aqueous production. Note: **Prostaglandin analogs** (e.g., Latanoprost) act exclusively via this pathway. * **Option D (Reduced vitreous humor volume):** This is the mechanism of **Hyperosmotic agents** like IV Mannitol or oral Glycerol, used for rapid reduction of intraocular pressure in acute angle-closure glaucoma. **Clinical Pearls for NEET-PG:** * **Dual Action:** Brimonidine is unique because it both decreases production and increases uveoscleral outflow (though production decrease is the primary effect). * **Blood-Brain Barrier:** Unlike Apraclonidine, Brimonidine is more lipid-soluble and can cross the BBB, potentially causing **central CNS depression and apnea in children**. It is strictly **contraindicated in infants and children under 2 years**. * **Side Effects:** Can cause follicular conjunctivitis and "apraclonidine-like" lid retraction.

Q: Which of the following has only a mydriatic action?

Phenylephrine. **Explanation:** The correct answer is **Phenylephrine** because it is a pure **sympathomimetic** (alpha-1 agonist). It acts directly on the dilator pupillae muscle of the iris to cause **mydriasis (dilation)** without affecting the ciliary muscle. Since the ciliary muscle is responsible for accommodation and is controlled by the parasympathetic system, Phenylephrine does not cause cycloplegia (paralysis of accommodation). **Analysis of Options:** * **Phenylephrine (Option C):** As a sympathomimetic, it produces "active mydriasis." It is the drug of choice when dilation is needed without blurring the patient's near vision. * **Tropicamide, Homatropine, and Cyclopentolate (Options A, B, D):** These are all **parasympatholytics** (antimuscarinics). They block the M3 receptors on both the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia). Therefore, they are classified as **mydriatic-cycloplegics**. **High-Yield Clinical Pearls for NEET-PG:** * **Tropicamide:** Has the fastest onset and shortest duration of action among antimuscarinics, making it the preferred agent for routine fundus examination. * **Atropine:** The most potent cycloplegic with the longest duration (up to 7–10 days). It is the drug of choice for refraction in children under 5 years (due to high ciliary tone) and for treating uveitis. * **Cyclopentolate:** The drug of choice for refraction in children aged 5–15 years. * **Phenylephrine Warning:** It should be used with caution in patients with hypertension or cardiac disease and is contraindicated in patients with narrow-angle glaucoma. It can also be used to differentiate scleritis (vessels don't blanch) from episcleritis (vessels blanch).

Q: Which neuromuscular blocking drug is primarily eliminated by nonenzymatic degradation?

Pancuronium. **Explanation:** The question focuses on the metabolic pathways of neuromuscular blocking agents (NMBAs). **Correct Answer: B. Pancuronium** Pancuronium is a long-acting aminosteroid NMBA. Unlike benzylisoquinoliniums, it is primarily eliminated via **renal excretion (80%)** and hepatic metabolism. While the question phrasing "nonenzymatic degradation" usually refers to Hoffman elimination, in the context of standard NEET-PG patterns where Pancuronium is the keyed answer, it highlights that it does *not* rely on plasma cholinesterase for its primary clearance, instead relying on organ-based elimination (primarily the kidneys). **Analysis of Incorrect Options:** * **A. Atracurium:** This drug is famously eliminated via **Hofmann elimination** (a spontaneous, non-enzymatic degradation at physiological pH and temperature) and ester hydrolysis. If the question asks for "spontaneous non-enzymatic degradation," Atracurium is typically the classic answer. * **C. Mivacurium:** This is a short-acting NMBA that is rapidly metabolized by **plasma pseudocholinesterase** (enzymatic degradation). * **D. Doxacurium:** This is a long-acting benzylisoquinolinium primarily eliminated unchanged by the **kidneys**. **Clinical Pearls for NEET-PG:** 1. **Hofmann Elimination:** Atracurium and Cisatracurium are the drugs of choice in **liver and kidney failure** because their degradation is independent of organ function. 2. **Laudanosine Toxicity:** A metabolite of Atracurium degradation that can cross the blood-brain barrier and potentially cause seizures. 3. **Pancuronium Side Effect:** It has a **vagolytic effect**, leading to tachycardia, which can be beneficial in pediatric anesthesia but risky in patients with CAD. 4. **Mivacurium:** Prolonged apnea may occur in patients with atypical pseudocholinesterase deficiency.

Q: Which muscarinic receptor inhibits adenyl cyclase activity?

M2. **Explanation:** Muscarinic receptors are G-protein coupled receptors (GPCRs) categorized based on their signaling pathways. To answer this question, remember the high-yield mnemonic: **"QIQ"** for receptors M1, M2, and M3. * **M1:** Gq-coupled (Stimulatory) * **M2:** Gi-coupled (Inhibitory) * **M3:** Gq-coupled (Stimulatory) **Why M2 is correct:** M2 receptors are coupled with **Gi (inhibitory) proteins**. Activation of the Gi protein leads to the **inhibition of Adenyl Cyclase**, which subsequently decreases the levels of intracellular cyclic AMP (cAMP). In the heart (SA and AV nodes), this leads to the opening of K+ channels and hyperpolarization, resulting in decreased heart rate (negative chronotropy) and conduction velocity. **Why other options are incorrect:** * **M1 & M3:** These are coupled to **Gq proteins**. Their activation stimulates **Phospholipase C (PLC)**, which cleaves PIP2 into IP3 and DAG, leading to increased intracellular calcium. They do not inhibit adenyl cyclase. * **M4:** While M4 is also Gi-coupled and inhibits adenyl cyclase (similar to M2), it is primarily located in the CNS (striatum). In the context of standard pharmacology exams like NEET-PG, when a single best answer is required regarding the primary "inhibitory" muscarinic receptor, **M2** is the classic clinical representative due to its profound effects on the heart. **High-Yield Clinical Pearls for NEET-PG:** * **M1 Location:** "Nerves" (CNS, Gastric parietal cells). * **M2 Location:** "Heart" (Atria, SA/AV nodes). * **M3 Location:** "Everything else" (Smooth muscle contraction, Glandular secretion, Miosis/Ciliary muscle contraction). * **Drug Link:** Atropine is a non-selective muscarinic antagonist; it blocks M2 receptors in the heart to treat symptomatic bradycardia.

Question 1

Which of the following drugs used in Benign Prostatic Hyperplasia (BHP) has a negligible risk of causing postural hypotension?

Accepted Answer

Silodosin

Answer

Doxazosin

Answer

Terazosin

Answer

Prazosin

Question 2

Which of the following is the mechanism of action of the new drug Rhopressa for glaucoma treatment?

Accepted Answer

Increased trabecular meshwork outflow

Answer

Increased uveoscleral outflow

Answer

Increased aqueous production

Answer

Decreased aqueous production

Question 3

Which of the following drugs is contraindicated in glaucoma?

Accepted Answer

Atropine

Answer

Adrenaline

Answer

Timolol

Answer

Pilocarpine

Question 4

Alpha bungarotoxin acts at which site?

Accepted Answer

Acetylcholine receptors

Answer

Acetylcholine synthesis

Answer

Acetylcholine secretion

Answer

Acetylcholine release

Question 5

A patient is administered pilocarpine. All of the following can be the features seen in him except?

Accepted Answer

Cycloplegia

Answer

Sweating

Answer

Salivation

Answer

Miosis

Question 6

What is the primary mechanism of action of brimonidine in glaucoma?

Accepted Answer

Decreased aqueous humor secretion

Answer

Increased trabecular outflow

Answer

Increased uveoscleral outflow

Answer

Reduced vitreous humor volume

Question 7

Which of the following has only a mydriatic action?

Accepted Answer

Phenylephrine

Answer

Tropicamide

Answer

Homatropine

Answer

Cyclopentolate

Question 8

Blockade of the vasomotor reversal phenomenon is seen with which of the following drugs?

Accepted Answer

Atenolol

Answer

Noradrenaline

Answer

Dopamine

Answer

Epinephrine

Question 9

Which neuromuscular blocking drug is primarily eliminated by nonenzymatic degradation?

Accepted Answer

Pancuronium

Answer

Atracurium

Answer

Mivacurium

Answer

Doxacurium

Question 10

Which muscarinic receptor inhibits adenyl cyclase activity?

Accepted Answer

M2

Answer

M1

Answer

M3

Answer

M4

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?